The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies-Reference-Cited by-同舟云学术

The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies

Published:2019-03-27 Issue:1 Volume:9 Page:
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clin Transl Allergy

Author:

Campbell Jonathan D.^ORCID,Perry Robert,Papadopoulos Nikolaos G.,Krishnan Jerry,Brusselle Guy,Chisholm Alison,Bjermer Leif,Thomas Michael,van Ganse Eric,van den Berge Maarten,Quint Jennifer,Price David,Roche Nicolas

Funder

European Academy of Allergy and Clinical Immunology

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13601-019-0256-9.pdf

Reference28 articles.

1. Global Asthma Network. The Global Asthma Report 2014. Auckland, New Zealand, 2014. Available online at: http://www.globalasthmareport.org/burden/burden.php .

2. Guyatt GH, Oxman AD, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schȕnemann HJ, GRADE Working Group. Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.

3. Herland K, Akselsen JP, Skjonsberg OH, Bjermer L. How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease? Respir Med. 2005;99:11–9.

4. Price D, Brusselle G, Roche N, Freeman D, Chisholm A. Real-world research and its importance in respiratory medicine. Breathe. 2015;11(1):26.

5. Rawlins M. De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet. 2008;372:2152–61.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world evidence of allergen immunotherapy;Current Opinion in Allergy & Clinical Immunology;2024-08-30

2. RIAIT (Italian Registry of Allergen Immunotherapy): Protocol for a New Tool in a New Vision of Disease-Modifying Therapy for Allergists;Journal of Personalized Medicine;2024-08-12

3. Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success;International Journal of Chronic Obstructive Pulmonary Disease;2024-05

4. A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort;Expert Review of Clinical Immunology;2023-12-19

5. The Size of a Thyroid Nodule with ACR TI-RADS Does Not Provide a Better Prediction of the Nature of the Nodule: A Single-Center Retrospective Real-Life Observational Study;Healthcare;2023-06-07